Adapalene
Indications
Registered South African indications:
- Acne vulgaris of the face, chest and back where comedones, papules and pustules predominate
Contraindications (ZA)
Registered South African contraindications
- Hypersensitivity to the active ingredient or any of its excipients
- Pregnancy
- Women planning a pregnancy
Warnings & precautions
South African recommendations
Caution in the following patient groups
- Breastfeeding
- Renal impairment
- Hepatic impairment
- Elderly
Excipient sensitivity (gel)
-
Adapalene gel contains methyl parahydroxybenzoate (E218) which can cause allergic reactions (which can arise after the treatment is completed) and propylene glycol which can be irritating to the skin
Excipient sensitivity (cream)
-
Adapalene cream contains methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216) which can cause allergic reactions (which can arise after the treatment is completed)
Sensitivity or severe irritation
-
If a reaction suggesting sensitivity or severe irritation occurs, use of adapalene should be discontinued
Management of local irritation
-
If the degree of local irritation warrants, patients should be directed to use the medication less frequently, to discontinue use temporarily, or to discontinue use altogether
Contact with sensitive areas
-
Adapalene should not come into contact with the eyes, mouth, angles of the nose, or mucous membranes. If adapalene comes into contact with the eye, wash immediately with warm water
Application restrictions
-
Adapalene should not be applied to broken skin (cuts and abrasions) or to eczematous skin
Severe acne and contraception
-
Adapalene should not be used in patients with severe acne involving large areas of the body, especially in women of childbearing age who are not on effective contraception. Adapalene should not be used in patients with severe acne
Sunlight and UV exposure
-
The safety of using adapalene during repeated exposure to sunlight or UV irradiation has not been established in either animals or man. Exposure to excessive sunlight or UV irradiation should therefore be avoided
Adult dosage (ZA)
Forms avail. in SA and covered in this monograph: cre, gel, jel
South African registered indications and dosages
Acne vulgaris of the face, chest and back where comedones, papules and pustules predominate
- Topical (cre, gel, jel): Apply small quantity to affected area(s), dly, after washing and before retiring
A thin film of the cream or gel should be applied avoiding the eyes, lips and mucous membranes. Adapalene cream and gel are not to be taken orally and is for cutaneous use only. If patients use cosmetics, these should be non-comedogenic and non-astringent
Clinical improvement is expected to be clearly evident after four to eight weeks of treatment with further improvement expected with continued use. With patients for whom it is necessary to reduce the frequency of application or to temporarily discontinue treatment, frequency of application may be restored or therapy resumed once it is judged that the patient can tolerate the treatment
Adapalene cream and gel should not be used in patients with severe acne
Paediatric dosage (ZA)
Not established for use in children below 12 years
Pregnancy & lactation
Pregnancy
South African recommendations
- Contraindicated
- Adapalene cream and gel are contraindicated in pregnancy, or in women planning a pregnancy
- In case of unexpected pregnancy, treatment should be discontinued
- Animal studies by the oral route have shown teratogenicity
Breastfeeding
South African recommendations
- Caution; not recommended
- No study on animal or human milk transfer was conducted after cutaneous application of adapalene cream and differin gel. Safety in lactation has not been demonstrated
- Adapalene should not be used during breastfeeding
Fertility
South African recommendations
- Orally administered retinoids have been associated with congenital abnormalities. When used in accordance with the prescribing information, topically administered retinoids are generally assumed to result in low systemic exposure due to minimal dermal absorption. However, there could be individual factors (e.g. damaged skin barrier, excessive use) that contribute to an increased systemic exposure
Renal impairment
South African recommendations
- Caution; no dose adjustment recommended
Hepatic impairment
South African recommendations
- Caution; no dose adjustment recommended
Elderly
South African recommendations
- Caution; no dose adjustment recommended
Adverse reactions
Skin and Subcutaneous Tissue Disorders
- Dry skin
- Skin irritation
- Skin burning sensation
- Erythema
- Contact dermatitis
- Skin discomfort
- Sunburn
- Pruritus
- Skin exfoliation
- Acne
- Allergic dermatitis
- Pain of skin
- Skin swelling
- Eyelid irritation
- Eyelid erythema
- Eyelid pruritus
- Eyelid swelling
Interactions
- Other retinoids
- Peeling agents, abrasive cleansers, strong drying agents, astringents or irritant products
Monitoring
None routine
Mechanism of action
Adapalene is a retinoid-like compound which is a modulator of cellular differentiation, keratinization, and inflammatory processes, all of which represent important features in the pathology of acne vulgaris.
Dosage forms
- Cream
- Jel, topical external
- Gel
Formulation
Gel (per g) 1mg
- Dapta (Litha Pharma)
- Deriva (Glenmark)
- Differin (Galderma) originator
Cream (per g) 1mg
- Dapta (Litha Pharma)
- Differin (Galderma) originator
COMBINATION PREPARATION
Adapalene/ Benzoyl peroxide
Gel (per g) 1mg/25mg
- Epiduo (Galderma) originator
References
1. PI - DIFFERIN CREAM and GEL - GALDERMA LABORATORIES - Date of revision of text - 4 September 2020 - Downloaded online 05 February 2026.pdf [https://pi-pil-repository.sahpra.org.za/wp-content/uploads/2022/10/pi-differin-approved.pdf] 2. https://www.medicines.org.uk/emc/product/920 (21/11/2018_ Galderma_cream) 3. https://www.medicines.org.uk/emc/product/921 (21/11/2018_ Galderma_gel) 4. https://drive.google.com/drive/folders/0B27NqM_vidrmeGxjUG9ZTnBLVzA differin package insert 5. https://www.drugs.com/pregnancy/adapalene-topical.html 6. https://www.uptodate.com/contents/adapalene-drug-information?source=search_result&search=adapalene&selectedTitle=1~23 7. NAPOS The Drug Database for Acute Porphyria: D10AD03 Adapalene; [Accessed online 11 Dec 2018http://www.drugs-porphyria.org/languages/UnitedKingdom/s3.php?atc_code=D10AD03&l=gbr] 8. South African Institute for Drug-Free Sport; Differin; Accessed online 11 Dec 2018 [http://www.drugfreesport.org.za/online-medication-check/]
Brands & products
5 products · stale NAPPI snapshot · refreshed 5/28/2026 · 159 days oldcreamGeneric· 2 products
from R12.38/unit| Product | Strength | Pack | Sched | SEP | Unit | Disp fee | NAPPI |
|---|---|---|---|---|---|---|---|
| Dapta Cream | 1 mg | 30 | S3 | R371.34 | R12.38 | R127.37 | 721707001 |
| Differin | 1 mg/g | 30 | S3 | R531.51 | R17.72 | R162.65 | 863939007 |
GelGeneric· 1 product
from R12.38/unit| Product | Strength | Pack | Sched | SEP | Unit | Disp fee | NAPPI |
|---|---|---|---|---|---|---|---|
| Dapta Gel | 1 mg | 30 | S3 | R371.34 | R12.38 | R127.37 | 721708001 |
gelGeneric· 2 products
from R13.92/unit| Product | Strength | Pack | Sched | SEP | Unit | Disp fee | NAPPI |
|---|---|---|---|---|---|---|---|
| Deriva gel | 1 mg/g | 30 | S3 | R417.56 | R13.92 | R140.08 | 720276001 |
| Differin gel | 1 mg/g | 30 | S3 | R531.51 | R17.72 | R162.65 | 827215002 |
- Dapta
- Deriva
- Differin
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.